1. Gilead says remdesivir cut risk of COVID patient death in clinical trial — BioNTech-Pfizer COVID vaccine expected to be ready for approval by year end — LEO Pharma eyeing 2021 launch for Dupixent rival — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

Eli Lilly IT


Sort By:
Title
Replies Views
Last Message ↓
  1. anonymous
    Replies:
    25
    Views:
    7,175
  2. anonymous
    Replies:
    2
    Views:
    2,476
  3. anonymous
    Replies:
    10
    Views:
    2,473
  4. anonymous
    Replies:
    19
    Views:
    6,462
  5. anonymous
    Replies:
    1
    Views:
    1,321
  6. anonymous
    Replies:
    5
    Views:
    2,128
  7. anonymous
    Replies:
    1
    Views:
    1,206
  8. anonymous
    Replies:
    27
    Views:
    7,031
  9. anonymous
    Replies:
    7
    Views:
    3,275
  10. anonymous
    Replies:
    11
    Views:
    2,531
  11. anonymous
    Replies:
    2
    Views:
    2,166
  12. anonymous
    Replies:
    5
    Views:
    3,969
  13. anonymous
    Replies:
    7
    Views:
    4,484
  14. anonymous
    Replies:
    5
    Views:
    3,787
  15. anonymous
    Replies:
    0
    Views:
    2,309
  16. anonymous
    Replies:
    2
    Views:
    2,367
  17. anonymous
    Replies:
    16
    Views:
    5,990
  18. Anonymous
    Replies:
    8
    Views:
    5,304
  19. anonymous
    Replies:
    9
    Views:
    3,163
  20. Anonymous
    Replies:
    10
    Views:
    5,094

Thread Display Options

Loading...